rdf:type |
|
lifeskim:mentions |
umls-concept:C0028125,
umls-concept:C0205314,
umls-concept:C0538674,
umls-concept:C0679622,
umls-concept:C0747055,
umls-concept:C0871261,
umls-concept:C1527148,
umls-concept:C1554080,
umls-concept:C1704410,
umls-concept:C1704632,
umls-concept:C1706198,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
8
|
pubmed:dateCreated |
2007-7-19
|
pubmed:abstractText |
Nitrate tolerance is likely attributable to an increased production of reactive oxygen species (ROS) leading to an inhibition of the mitochondrial aldehyde dehydrogenase (ALDH-2), representing the nitroglycerin (GTN) and pentaerythrityl tetranitrate (PETN) bioactivating enzyme, and to impaired nitric oxide bioactivity and signaling. We tested whether differences in their capacity to induce heme oxygenase-1 (HO-1) might explain why PETN and not GTN therapy is devoid of nitrate and cross-tolerance.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1524-4636
|
pubmed:author |
pubmed-author:ColdeweyMeikeM,
pubmed-author:DaiberAndreasA,
pubmed-author:FörstermannUlrichU,
pubmed-author:HinkUlrichU,
pubmed-author:HortmannMarcusM,
pubmed-author:HsiaoH CHC,
pubmed-author:LehmannJochenJ,
pubmed-author:MünzelThomasT,
pubmed-author:MollnauHankeH,
pubmed-author:OelzeMatthiasM,
pubmed-author:SeelingAndreasA,
pubmed-author:StalleickenDirkD,
pubmed-author:WeinerHenryH,
pubmed-author:WenzelPhilipP
|
pubmed:issnType |
Electronic
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1729-35
|
pubmed:meshHeading |
pubmed-meshheading:17541025-Aldehyde Dehydrogenase,
pubmed-meshheading:17541025-Animals,
pubmed-meshheading:17541025-Chromatography, High Pressure Liquid,
pubmed-meshheading:17541025-Cyclic GMP,
pubmed-meshheading:17541025-Disease Models, Animal,
pubmed-meshheading:17541025-Drug Tolerance,
pubmed-meshheading:17541025-Endothelium, Vascular,
pubmed-meshheading:17541025-Free Radical Scavengers,
pubmed-meshheading:17541025-Heme Oxygenase-1,
pubmed-meshheading:17541025-Male,
pubmed-meshheading:17541025-Nitroglycerin,
pubmed-meshheading:17541025-Pentaerythritol Tetranitrate,
pubmed-meshheading:17541025-Probability,
pubmed-meshheading:17541025-Random Allocation,
pubmed-meshheading:17541025-Rats,
pubmed-meshheading:17541025-Rats, Wistar,
pubmed-meshheading:17541025-Reactive Oxygen Species,
pubmed-meshheading:17541025-Reference Values,
pubmed-meshheading:17541025-Sensitivity and Specificity
|
pubmed:year |
2007
|
pubmed:articleTitle |
Heme oxygenase-1: a novel key player in the development of tolerance in response to organic nitrates.
|
pubmed:affiliation |
II. Medizinische Klinik, Johannes-Gutenberg-Universität Mainz, Langenbeckstr. 1, 55131 Mainz, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|